At NEVOFARMA, we partner with leading pharmaceutical innovators to bring advanced treatments to regions with unmet medical needs and improve patient outcomes through science, access, and care.

At NEVOFARMA, we partner with leading pharmaceutical innovators to bring advanced treatments to regions with unmet medical needs and improve patient outcomes through science, access, and care.

NEVOFARMA is a pharmaceutical access and distribution company committed to bridging global innovation with patients in need. By collaborating with biotechnology innovators, international pharmaceutical manufacturers, and healthcare institutions, we support the introduction of advanced therapies—especially for rare and underserved conditions.
Our work is guided by scientific integrity, regulatory excellence, and a firm dedication to improving patient outcomes across diverse healthcare systems.
Expanding access to these therapies is a real challenge in many parts of the world, due to different barriers. Just at that point, NEVOFARMA works to bridge the gap by partnering with pharmaceutical innovators to bring advanced therapies where they are needed most.

Globally, over 300 million people are affected by rare diseases.
Approximately 50% of rare diseases begin in childhood.

Patients consult an average of 10 doctors before receiving a diagnosis.